Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 2023
A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 YearsM N Gaze, N Smeulders, R Ackwerh, et al.
Cancer|December 7, 2017
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 studyBas Vaarwerk, Johanna H van der Lee, Willemijn B Breunis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyAndrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.
British Journal of Cancer|April 13, 2024
Radiation Reveal: Moving from research engagement to involvementLisa Whittaker, Jamie A Dean, Catarina Veiga, et al.
Frontiers in Pediatrics|June 8, 2026
DENTALE: a validated Dentofacial EvaluatioN Tool to standardize radiological Assessment of Late dental and maxillofacial adverse Effects following treatment for pediatric rhabdomyosarcomaKoen B Krommenhoek, Reinier C Hoogeveen, E Foster-Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2021
Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter surveySophie C Huijskens, Petra S Kroon, Mark N Gaze, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 21, 2026
Systematic review of facial deformation following paediatric head and neck radiation therapy: A call for standardised outcome assessment and dose-response evidenceAngela Davey, Lucy Siew Chen Davies, Shermaine Pan, et al.
The Lancet. Oncology|November 17, 2018
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, et al.
Practical Radiation Oncology|February 19, 2026
Systematic Review of Late Dental Effects Following Head and Neck Radiation Therapy in Childhood Cancer SurvivorsKoen B Krommenhoek, Emma Foster-Thomas, Angela Davey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2024
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelinesRaquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, et al.
Pageof 14